What is the appropriate management for a patient who develops an allergic reaction during or shortly after receiving an influenza or pneumococcal vaccine?

Management of Allergic Reactions to Influenza or Pneumococcal Vaccines

If a patient develops an allergic reaction during or shortly after receiving an influenza or pneumococcal vaccine, immediately assess the severity and treat anaphylaxis with intramuscular epinephrine if present, then determine whether the reaction represents a true contraindication to future vaccination based on the specific vaccine type and reaction characteristics. 1

Immediate Management (During or Within 4 Hours of Vaccination)

Recognition and Treatment

All vaccination sites must have personnel trained in recognizing and managing anaphylaxis, with equipment immediately available including epinephrine, oxygen, antihistamines, corticosteroids, vasopressors, oral airways, and IV fluid administration capability 2, 3.

For suspected anaphylaxis:

• Administer intramuscular epinephrine immediately
• Activate emergency response
• Provide supportive care (oxygen, IV fluids, positioning)
• Monitor for biphasic reactions

Observation Periods

• Standard observation: 15 minutes post-vaccination for all patients to monitor for syncope 4
• Extended observation: 30 minutes for patients with history of severe egg allergy receiving egg-based vaccines 2
• Note: While most reactions occur within 30 minutes, delayed systemic reactions can occur up to 6 hours later, though these are generally not severe 5

Classification of Reactions

Immediate Reactions (Within 4 Hours)

These are potentially IgE-mediated and require allergy workup 6:

• Anaphylaxis: Multi-system involvement with cardiovascular or respiratory compromise
• Isolated urticaria (hives): Skin-only reaction
• Angioedema: Swelling of lips, tongue, or face
• Respiratory distress: Wheezing, throat tightness
• Gastrointestinal: Recurrent vomiting, severe nausea

Non-Immediate Reactions (After 4 Hours)

• Generally do not represent IgE-mediated hypersensitivity
• Local injection site reactions are most common and do not require allergy workup 6

Future Vaccination Decisions

For Influenza Vaccines

If the patient had a severe allergic reaction (anaphylaxis) to a previous influenza vaccine:

The approach depends on which vaccine caused the reaction 1:

Previous Vaccine	Can Use	Precaution	Contraindicated
Egg-based IIV or LAIV	ccIIV or RIV	ccIIV or RIV*	Egg-based vaccines
ccIIV	Egg-based IIV or LAIV	RIV*	ccIIV
RIV	Egg-based IIV or LAIV	ccIIV*	RIV

*When used as "precaution," vaccine must be administered in a medical setting supervised by a provider capable of managing severe allergic reactions. Consider allergist consultation to identify the responsible component 1.

If the vaccine type is unknown: Allergist consultation is recommended before any future influenza vaccination 1.

For Egg Allergy (Not Vaccine Reaction)

The 2024 guidelines have liberalized recommendations significantly 4, 7:

Patients with history of only urticaria after egg exposure:

• Can receive any licensed, age-appropriate influenza vaccine (IIV, RIV4, or LAIV4)
• No special precautions needed beyond standard observation

Patients with severe egg reactions (angioedema, respiratory distress, recurrent vomiting, or required epinephrine):

• Can still receive any licensed, age-appropriate influenza vaccine
• Must be administered in a medical setting with supervision by a provider capable of managing severe allergic reactions
• No extended observation period specifically required for egg allergy

Practical assessment:

• Patients who can eat lightly cooked eggs (scrambled eggs) without reaction are unlikely to be allergic and can receive vaccine per usual protocol 2

For Pneumococcal Vaccines

A severe allergic reaction to any pneumococcal vaccine is a contraindication to future doses of that specific vaccine type 1, 8.

For PCV13-vaccinated adults or those with prior PPSV23, specific algorithms exist for completing the series with PCV20 or PCV21, but a history of anaphylaxis to any component contraindicates that vaccine 9.

Key Distinctions and Pitfalls

Component-Specific Allergies

The reaction may be to vaccine components rather than the antigen itself 10:

• Gelatin: Present in some vaccines; known gelatin allergy requires workup before vaccination 6, 11
• Yeast: In some vaccines; yeast allergy requires evaluation 6
• Antibiotics: Trace amounts may be present 6
• Latex: From vial stoppers; latex allergy requires latex-free administration 12
• Thimerosal: Rarely causes true anaphylaxis; usually causes delayed-type local hypersensitivity 13

Not True Allergic Reactions

Vasovagal reactions can mimic allergic reactions but are not contraindications to future vaccination 5. These typically involve:

• Pallor, diaphoresis
• Bradycardia (not tachycardia)
• Rapid recovery when supine
• No urticaria, angioedema, or bronchospasm

Coincidental Illness

Respiratory symptoms after vaccination often represent coincidental illness unrelated to the vaccine, as inactivated vaccines cannot cause influenza 13.

Documentation Requirements

Document the following for any suspected allergic reaction:

• First symptom and time of onset after injection 5
• All symptoms and organ systems involved
• Treatment provided and response
• Whether epinephrine was administered and timing
• Final assessment of reaction grade/severity

This documentation is critical for determining future vaccination eligibility and approach.

Special Populations

Patients on beta-blockers: These individuals are at higher risk for severe, treatment-resistant anaphylaxis 5, 3. While not an absolute contraindication, extra caution is warranted, and some practitioners may consider temporarily discontinuing beta-blockers before vaccination when medically appropriate.

Immunocompromised patients: Live vaccines (LAIV) are contraindicated, but inactivated vaccines (IIV, RIV, PCV, PPSV23) can be administered 8, 12.